ClinicalTrials.Veeva

Menu

START - Early Thrombocyte Administration to Patients With Ruptured Abdominal Aortic Aneurism (rAAA)

Rigshospitalet logo

Rigshospitalet

Status

Unknown

Conditions

Ruptured Abdominal Aortic Aneurism

Treatments

Procedure: Platelet

Study type

Interventional

Funder types

Other

Identifiers

NCT01291290
H-D-2009-002

Details and patient eligibility

About

The purpose of this study is to investigate the effect of platelet infusion prior to transfer to a vascular surgical department in patients with a ruptured abdominal aortic aneurism.

Enrollment

420 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • diagnosed with rAAA either by clinical evaluation or CT or UL

Exclusion criteria

  • formerly randomized in the study
  • aneurism not ruptured during operation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Triple Blind

420 participants in 2 patient groups

Control treatment
No Intervention group
Description:
Usual transfusion regime to patients with rAAA
Thrombocyte
Experimental group
Description:
Early thrombocyte administration to patients with rAAA
Treatment:
Procedure: Platelet

Trial contacts and locations

1

Loading...

Central trial contact

Thomas Bech Jørgensen, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems